Drug holidays may not affect processing speed while they may reduce beneficial effects on resistance to interference among children with treated with methylphenidate: a single-center, prospective study

References

• American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. 5th ed. (DSM-5). Arlington (VA): APA; 2013.
   Google Scholar
• Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics. 2012;9(3):490–499.
   PubMed Web of Science ®Google Scholar
• Polanczyk G, De Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942–948.
   PubMed Web of Science ®Google Scholar
• Plizska S. AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attentiondeficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management (NICE Guideline 87). London: National Institute for Health and Care Excellence. 2018.
   Google Scholar
• Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment. 4th ed. Newyork: Oxford University Press; 2004.
   Google Scholar
• Sonuga-Barke E, et al. Pathogenesis. In: Banaschewski T, Coghill D, Danckaerts M, Dpfner M, Rohde L, Sergeant JA, editors. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Oxford: Oxford University Press; 2010. p. 19–32. 7–8.
   Google Scholar
• Jiang X, Liu L, Ji H, et al. Association of affected neurocircuitry with deficit of response inhibition and delayed gratification in attention deficit hyperactivity disorder: a narrative review. Front Hum Neurosci. 2018;12:506.
   PubMed Web of Science ®Google Scholar
• Thapar A, Cooper M. Attention deficit hyperactivity disorder. Lancet. 2016;387(10024):1240–1250.
   PubMed Web of Science ®Google Scholar
• Tasdelen BI, Karakaya E, Oztop DB. Effects of atomoxetine and osmotic release oral system-methylphenidate on executive functions in patients with combined type attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2015;25(6):494–500.
   PubMed Web of Science ®Google Scholar
• Karakaya I, Öç ÖY, Şişmanlar ŞG, et al. The effect of methylphenidate on attention and executive functioning in the children with ADHD: A case serial. Turkish J Child Adolesc Ment Heal. 2006;13(2):69–75.
   Google Scholar
• Yarmolovsky J, Szwarc T, Schwartz M, et al. Hot executive control and response to a stimulant in a double-blind randomized trial in children with ADHD. Eur Arch Psychiatry Clin Neurosci. 2017;267(1):73–82.
   PubMed Web of Science ®Google Scholar
• Alliance CADHDR, (CADDRA). Canadian ADHD Practice Guidelines. 4th ed. Toronto (ON): CADDRA; 2018.
   Google Scholar
• Gormez V. Psychopharmacological management of Attention Deficit/Hyperactivity Disorder. In: Pekcanlar Akay A, Ercan ES, editors. Textbook of child and adolescent mental health and disorders. Ankara: ADHD; 2016. p. 56–74.
   Google Scholar
• Ercan ES, Avcı A, Mukaddes Nm Semerci B, et al. Attention deficit hyperactivity disorder clinical practice guideline. İstanbul: Janssen-Cilag; 2008.
   Google Scholar
• Ercan ES. Attention deficit hyperactivity disorder expert consensus report. Turkey-İstanbul: Department of Child and Adolescent Psychiatry; 2013.
   Google Scholar
• Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980–988.
   PubMed Web of Science ®Google Scholar
• Gökler B, Ünal F, Pehlivantürk B. Reliability and validity of the Turkish version of the Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version. J Child Adolesc Ment Health. 2004;11(3):109–116.
   Google Scholar
• Guy W. Clinical Global Impression (CGI). In: (NIMH) NI of MH, editor. ECDEU Assesment manual for psycopharmacology. Rockville (MD): NIMH; 1976.
   Google Scholar
• Goyette CH, Conners CK, Ulrich RF. Normative data on revised conners parent and teacher rating scales. J Abnorm Child Psychol. 1978;6(2):221–236.
   PubMed Web of Science ®Google Scholar
• Dereboy Ç, Şenol S, Şener Ş, et al. Reliability and validity of the Conners Teacher Rating Scale – Short Form and Parental Rating Scale- Short Form. J Child Adolesc Ment Health. 2007;18(1):48–58.
   Google Scholar
• Kaner S, Büyüköztürk Ş, İşeri E. Conners teacher rating scale-revised short: Turkish adaptation study. Educ Sci. 2013;38:167.
   Web of Science ®Google Scholar
• Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18(6):643–662.
   Google Scholar
• Karakaş S, Doğutepe Dinçer E. BILNOT battery handbook: research and development studies of neuropsychological tests for children-child. (Vol. 1). İstanbul: Nobel Tıp Kitabevleri; 2011.
   Google Scholar
• Kılıç BG, İlden Koçkar A, Irak M, et al. The standardization study of the stroop test TBAG form in children between 6 and 11 years of age. Turkish J Child Adolesc Ment Heal. 2002;9:2.
   Google Scholar
• Spreen O, Strauss E. A compendium of neuropsychological tests: Administration, norms, and commentary. New York (NY): Oxford University Press; 1991.
   Google Scholar
• Karakaş S, Erdoğan E, Soysal Ş, et al. Stroop Test TBAG Form: Standardisation for Turkish culture, reliability and validity. Turkish J Clin Psychiatry. 1999;2(2):75–88.
   Google Scholar
• Bolfer C, Pacheco SP, Tsunemi MH, et al. Attention-deficit/hyperactivity disorder: the impact of methylphenidate on working memory, inhibition capacity and mental flexibility. Arq Neuropsiquiatr. 2017;75(4):204–208.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Liang JM, Gao HY, et al. An open-label, self-control, prospective study on cognitive function, academic performance, and tolerability of osmotic-release oral system methylphenidate in children with attention-deficit hyperactivity disorder. Chin Med J. 2015;128(22):2988–2997.
   PubMed Web of Science ®Google Scholar
• Wilens TE, McBurnett K, Bukstein O, et al. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2006;160(1):82–90.
   PubMedGoogle Scholar
• Martins S, Tramontina S, Polanczyk G, et al. Weekend holidays during methylphenidate use in ADHD children: a randomized clinical trial. J Child Adolesc Psychopharmacol. 2004;14(2):195–206.
   PubMed Web of Science ®Google Scholar
• Ibrahim K, Donyai P. Drug holidays from ADHD medication: international experience over the past four decades. J Atten Disord. 2015;19(7):551–568.
   PubMed Web of Science ®Google Scholar